{
    "2019-04-03": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Biogen SMA drug price, Novartis estimates for its treatment far too high: U.S. group",
                "features": {
                    "keywords": [
                        "Biogen",
                        "SMA",
                        "drug",
                        "price",
                        "Novartis",
                        "estimates",
                        "high",
                        "U.S.",
                        "group"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-04",
                "original_text": "Roche Extends Offer Period for Spark Therapeutics Acquisition",
                "features": {
                    "keywords": [
                        "Roche",
                        "Extends",
                        "Offer",
                        "Period",
                        "Spark",
                        "Therapeutics",
                        "Acquisition"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-10",
                "original_text": "Allergan's AMD Drug Lowers Inflammation in Phase III Study",
                "features": {
                    "keywords": [
                        "Allergan",
                        "AMD",
                        "Drug",
                        "Lowers",
                        "Inflammation",
                        "Phase",
                        "III",
                        "Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-20",
                "original_text": "After inking lease with cancer-fighting company, this new East Bay biotech project is full",
                "features": {
                    "keywords": [
                        "lease",
                        "cancer-fighting",
                        "company",
                        "East",
                        "Bay",
                        "biotech",
                        "project"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-12",
                "original_text": "The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings",
                "features": {
                    "keywords": [
                        "Daily",
                        "Biotech",
                        "Pulse",
                        "Advaxis",
                        "Offering",
                        "Roche",
                        "Spark",
                        "Tender",
                        "Offer",
                        "Extended",
                        "Ascendis",
                        "Earnings"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-01",
                "original_text": "Novartis's Alcon spinoff ousts Baer from Swiss benchmark SMI",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Alcon",
                        "spinoff",
                        "ousts",
                        "Baer",
                        "Swiss",
                        "benchmark",
                        "SMI"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}